AlphaYouMR
Insider selling
Matthew R Henn sold $580 of Seres Therapeutics, Inc. (MCRB) stock
Matthew R Henn sold 77 shares of MCRB stock worth $580, per an SEC Form 4 filed May 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 15, 2026, 4 days before it was made public.
MCRB has moved -46.7% since the trade date, from $7.64 to $4.07 (Sep 21, 2026 close).
- Traded
- May 15, 2026
- Disclosed
- May 19, 2026
- Filing delay
- 4 days
- Price since
- -46.7%
- Source
- SEC Form 4
More MCRB insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.